S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NASDAQ:MMSI

Merit Medical Systems (MMSI) Stock Price, News & Analysis

$75.46
+2.55 (+3.50%)
(As of 03/27/2024 ET)
Today's Range
$73.58
$75.51
50-Day Range
$71.86
$81.25
52-Week Range
$62.58
$85.62
Volume
488,304 shs
Average Volume
546,162 shs
Market Capitalization
$4.37 billion
P/E Ratio
46.58
Dividend Yield
N/A
Price Target
$93.00

Merit Medical Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
23.2% Upside
$93.00 Price Target
Short Interest
Healthy
3.90% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.16
Upright™ Environmental Score
News Sentiment
0.88mentions of Merit Medical Systems in the last 14 days
Based on 14 Articles This Week
Insider Trading
Selling Shares
$5.35 M Sold Last Quarter
Proj. Earnings Growth
10.57%
From $3.31 to $3.66 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.86 out of 5 stars

Medical Sector

40th out of 939 stocks

Surgical & Medical Instruments Industry

6th out of 96 stocks

MMSI stock logo

About Merit Medical Systems Stock (NASDAQ:MMSI)

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

MMSI Stock Price History

MMSI Stock News Headlines

Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
MMSI Oct 2024 50.000 put
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Demystifying Merit Medical Systems: Insights From 5 Analyst Reviews
Q4 2023 Merit Medical Systems Inc Earnings Call
Merit Medical Systems: Q4 Earnings Insights
See More Headlines
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/28/2024
Next Earnings (Confirmed)
4/30/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:MMSI
CUSIP
58988910
Employees
6,950
Year Founded
1987

Price Target and Rating

Average Stock Price Target
$93.00
High Stock Price Target
$112.00
Low Stock Price Target
$81.00
Potential Upside/Downside
+23.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

Net Income
$94.41 million
Pretax Margin
8.91%

Debt

Sales & Book Value

Annual Sales
$1.26 billion
Cash Flow
$5.00 per share
Book Value
$20.81 per share

Miscellaneous

Free Float
55,758,000
Market Cap
$4.37 billion
Optionable
Optionable
Beta
0.90

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

MMSI Stock Analysis - Frequently Asked Questions

Should I buy or sell Merit Medical Systems stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MMSI shares.
View MMSI analyst ratings
or view top-rated stocks.

What is Merit Medical Systems' stock price target for 2024?

8 analysts have issued 12-month price objectives for Merit Medical Systems' shares. Their MMSI share price targets range from $81.00 to $112.00. On average, they anticipate the company's share price to reach $93.00 in the next year. This suggests a possible upside of 23.2% from the stock's current price.
View analysts price targets for MMSI
or view top-rated stocks among Wall Street analysts.

How have MMSI shares performed in 2024?

Merit Medical Systems' stock was trading at $75.96 at the start of the year. Since then, MMSI stock has decreased by 0.7% and is now trading at $75.46.
View the best growth stocks for 2024 here
.

When is Merit Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 30th 2024.
View our MMSI earnings forecast
.

How can I listen to Merit Medical Systems' earnings call?

Merit Medical Systems will be holding an earnings conference call on Tuesday, April 30th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its earnings results on Wednesday, February, 28th. The medical instruments supplier reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.77 by $0.04. The medical instruments supplier earned $324.52 million during the quarter, compared to analyst estimates of $320.66 million. Merit Medical Systems had a net margin of 7.51% and a trailing twelve-month return on equity of 14.63%. The company's revenue for the quarter was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.79 EPS.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of 3.280-3.350 for the period, compared to the consensus EPS estimate of 3.320. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.92%), Vanguard Group Inc. (11.91%), Conestoga Capital Advisors LLC (3.73%), Dimensional Fund Advisors LP (2.26%), Price T Rowe Associates Inc. MD (1.41%) and Price T Rowe Associates Inc. MD (1.41%). Insiders that own company stock include A Scott Anderson, Brian G Lloyd, F Ann Millner, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Michel James Voigt, Neil Peterson, Raul Jr Parra, Ronald Frost and Thomas James Gunderson.
View institutional ownership trends
.

How do I buy shares of Merit Medical Systems?

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Merit Medical Systems have any subsidiaries?
The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.
Read More
This page (NASDAQ:MMSI) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners